Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay

Journal of Steroid Biochemistry and Molecular Biology

Volumn 101, Issue 1, 2006, Pages 68-77

  Roy, Partha ^a   Franks, Stephen ^a   Read, Moira ^a   Huhtaniemi, Ilpo T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Androgen; Androgen receptor; Bioassay; Luciferase; Polycystic ovarian syndrome

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; CYPROTERONE ACETATE; DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYFLUTAMIDE; INDUSTRIAL CHEMICAL; LUCIFERASE; PESTICIDE; PROGESTERONE; TESTOSTERONE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; BLOOD LEVEL; BLOOD SAMPLING; CELL LINE; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE MAMMARY TUMOR ONCOVIRUS; OVARY POLYCYSTIC DISEASE; PLASMID; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

ANDROGENS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PROTEIN BINDING; RECEPTORS, ANDROGEN; RECOMBINATION, GENETIC; SENSITIVITY AND SPECIFICITY; TESTOSTERONE; TRANS-ACTIVATION (GENETICS);

MOUSE MAMMARY TUMOR VIRUS;

EID: 33748064349     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.06.014     Document Type: Article

References (26)

1. Keller E.T., Ershler W.B., and Chang C. The androgen receptor: a mediator of diverse responses. Front. Biosci. 1 (1996) 59-71
2. Blankvoort B.M.G., de Groene E.M., van Meeteren-Kreikamp A.P., Witkamp R.F., Rodenburg R.J.T., and Aarts J.M.M.G. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. Anal. Biochem. 298 (2001) 93-102
3. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
4. Raivio T., Palvimo J.J., Dunkel L., Wickman S., and Janne O.A. Novel assay for determination of androgen bioactivity in human serum. J. Clin. Endocrionl. Metab. 86 (2001) 1539-1544
5. Langley E., Zhou Z.-X., and Wilson E.M. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor. J. Biol. Chem. 270 (1995) 29983-29990
6. Doesburg P., Kuil C.W., Berrevoets C.A., Steketee K., Faber P.W., Mulder E., Brinkmann A.O., and Trapman J. Functional in vivo interaction between the amino terminal, transactivation domain and the ligand-binding domain of the androgen receptor. Biochemistry 36 (1997) 1052-1064
7. Ikonen T., Palvimo J.J., and Janne O.A. Interaction between the amino- and carboxy-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272 (1997) 29821-29828
8. Kemppainen J.A., Langley E., Wong C.I., Bobseine K., Kelce W.R., and Wilson E.M. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 13 (1999) 440-454
9. Paris F., Servant N., Terouanne B., and Sultan C. Evaluation of androgenic bioactivity in human serum by recombinant cell line: preliminary results. Mol. Cell. Endocrinol. 198 (2002) 123-129
10. Raivio T., Toppari J., Kaleva M., Virtanen H., Haavisto A.-M., Dunkel L., and Janne O.A. Serum androgen bioactivity in cryptorchid and noncryptoorchid boys during the postnatal reproductive hormone surge. J. Clin. Endocrinol. Metab. 88 (2003) 2597-2599
11. Raivio T., Dunkel L., Wickman S., and Janne O.A. Serum androgen bioactivity in adolescence: a longitudinal study of boys with constitutional delay in puberty. J. Clin. Endocrinol. Metab. 89 (2004) 1188-1192
12. Roy P., Salminen H., Koskimies P., Simola J., Smeds A., Saukko P., and Huhtaniemi I.T. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J. Steroid Biochem. Mol. Biol. 88 (2004) 157-166
13. Chomczynski P., and Sacchi N. Single step method of RNA isolation by guanidiumthiocyanate phenol chloroform extraction. Anal. Biochem. 162 (1987) 156-189
14. Vinggaard A.M., Joergensen E.C.B., and Larsen J.C. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals. Toxicol. Appl. Pharmacol. 155 (1999) 150-160
15. Rignold G.M., Dobson D.E., Grove J.R., Hall C.V., Lee F., and Vannice J.L. Glucocorticoid regulation of gene expression: moue mammary tumor virus as a model system. Recent Prog. Horm. Res. 39 (1983) 387-421
16. Shen P., Xie Z.-J., Li H., and Sanchez E.R. Glucocorticoid receptor conversion to high affinity nuclear binding and transcription enhancement activity in Chinese Hamster Ovary cells subjected to heat and chemical stress. J. Steroid Biochem. Mol. Biol. 47 (1993) 55-64
17. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., and Bonefeld-Jorgensen E.C. Effects of currently used pesticides in assays for estrogenecity, androgenecity and aromatase activity in vitro. Toxicol. Appl. Pharmacol. 179 (2002) 1-12
18. Deslypere J.P., Young M., Eilson J.D., and McPhaul M.J. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol. Cell. Endocrinol. 88 (1992) 15-22
19. Dorfman R.I. Androgens and anabolic agents. In: Dorfman R.I. (Ed). Methods in Hormone Research vol. 2 (1962), Academic Press, New York 275-313
20. Shimamura M., Kodaira K., Kenichi H., Ishimito Y., Tamura H., and Iguichi T. Comparison of antiandrogenic activities of vinclozolin and d,l-camphorquinone in androgen receptor gene transcription assay in vitro and in utero exposure assay in vivo. Toxicology 174 (2002) 97-107
21. Klein K.O., Baron J., Colli M.J., McDonnell D.P., and Cutler G.B. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J. Clin. Invest. 94 (1994) 2475-2480
22. Moilanen A.M., Rouleau N., Ikonen T., Palvimo J.J., and Janne O.A. The presence of a transcription activation function in the hormone-binding domain of an androgen receptor revealed by studies in yeast cells. FEBS Lett. 412 (1998) 355-358
23. Blankvoort B.M., Aarts J.M., Schilt R., Geerdink P., Spenkelink B., and Rodenburg R.J. Detection of hormonal anabolic compounds in calf urine and unverified growth-promoting preparations: application of the AR-LUX bioassays for screening and determination of androgenic activity. Analyst 128 (2003) 1373-1381
24. Miyamoto H., Yeh S., Lardy H., Messing E., and Chang C. Delta 5-androstenediol is a natural hormone with androgenic activity in the human prostate cancer cells. Proc. Natl. Acad. Sci. USA 95 (1998) 11083-11088
25. Terouanne B., Tahiri B., Georget V., Belon C., Poujol N., Avances C., Orio F., Orio Jr. P., Balaguer P., and Sultan C. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol. Cell. Endocrinol. 160 (2000) 39-49
26. Jenster G., Spenser T.E., Burein M.M., Tsai S.Y., Sai M.J., and O'Malley B.W. Steroid receptor induction of gene transcription: a two-step model. Proc. Natl. Acad. Sci. USA 94 (1997) 7879-7884